Tom Sailer

Tom Sailer is an accomplished professional in strategy and analytics, currently serving as SVP of Strategy and Analytics at BW Health Group since November 2023. In this role, Tom leads strategic initiatives for the launch of Mitsubishi Tanabe Pharma America's ENGOLCE for Parkinson's Disease and RADICAVA for Amyotrophic Lateral Sclerosis, along with various new business ventures. Prior experience includes significant roles at Klick as VP of Strategy, Merkle as Group Director of Integrated Strategy in Healthcare, and SVP positions at HealthMasters Communications and Havas Life. Tom's extensive background in healthcare strategy is underpinned by an MFA degree from New York University.